Flaw cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in submucosal carcinoma of the esophagus

Hepato-Gastroenterology

Volumn 46, Issue 25, 1999, Pages 285-289

  Kimura, Hironobu ^a   Konishi, Kohji ^a   Maeda, Kiichi ^a   Yabushita, Kazuhisa ^a   Kuroda, Yoshitaka ^a   Tsuji, Masahiko ^a   Miwa, Atsuo ^a  

^a TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Flow cytometry; p53; PCNA; Submucosal esophageal cancer

Indexed keywords

CYCLINE; PROTEIN P53; DNA;

ADULT; AGED; ANEUPLOIDY; ARTICLE; DIPLOIDY; DNA CONTENT; ESOPHAGUS CARCINOMA; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SUBMUCOSA; ESOPHAGUS TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032587371     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. 1 Skinner DB, Dowlatshahi KD, DeMeester TR: Potentially curable cancer of the esophagus. Cancer 1982; 50:1641-1645.
2. 2 Sugimachi K, Ohno S, Matsuda H, et al: Clinicopathologic study of early stage esophageal carcinoma. Surgery 1989; 105:706-710.
3. 3 Sugimachi K, Kitamura K, Matsuda H, et al: Proposed new criteria for early carcinoma of the esophagus. Surg Gynecol Obstet 1991; 173:303-308.
4. 4 Haruma K, Tokutomi T, Tsuda T, et al: Superficial esophageal carcinoma: A report of 27 cases in Japan. Am J Gastroenterol 1991; 86:1723-1728.
5. 5 Goseki N, Koike M, Yoshida M: Histopathologic characteristics of early stage esophageal carcinoma. Cancer 1992; 69:1088-1093.
6. 6 Kimura H, Yonemura Y, Epstein AL: Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in advanced gastric cancers. Cancer 1991; 68:2175-2180.
7. 7 Kimura H, Yonemura Y, Miyazaki I: Proliferative activity in advanced gastric cancer with Ki-67 and propidium iodide: Analysis by flow cytometry. Int J Oncol 1992; 1:265-269.
8. 8 Kimura H, Yonemura Y, Miyazaki I: Proliferative activity in gastric cancer determined with cell cycle-related monoclonal antibodies Ki-67 and p105: Analysis by flow cytometry. J Surg Oncol 1992; 51:174-178.
9. 9 Bravo R, Frank R, Blundell PA, MacDonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase alpha. Nature 1987; 326:515-517.
10. 10 Mercer WE, Avignolo C, Beserga R: Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies. Mol Cell Biol 1984; 4:276-282.
11. 11 Schutte B, Reynders MMJ, Bosman FT, Blijham GH: Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 1985; 6:26-30.
12. 12 Japanese Society for Esophageal Diseases: "Guidelines for the clinical and pathologic studies on the carcinoma of the esophagus". 8th Edition. Tokyo: Kanehara, 1992.
13. 13 Endo M, Yoshino K, Takeshita K, Kuwano T: Analysis of 1125 cases of early esophageal carcinoma in Japan. Disease of the Esophagus 1991; 4:71-76.
14. 14 Kodama M, Kakegawa T: Treatment of superficial carcinoma of the esophagus - A review of responses to questionnaire on superficial carcinoma of the esophagus collected at the 49th conference of Japanese Society for Esophageal Diseases. J Jpn Surg Soc 1996; 97:683-690.
15. 15 Kimura H, Yonemura Y: Flow cytometric analysis of nuclear DNA content in advanced gastric cancer and its relationship with prognosis. Cancer 1991; 67:2588-2593.
16. 16 Kimura H, Yonemura Y, Kadoya N, et al: Correlation between DNA ploidy and clinical features in smooth muscle tumors of the gastrointestinal tract. Analy Cell Path 1993; 5:331-338.
17. 17 Kimura H, Kanno M, Takamura H, et al: Implications of flow cytometry in preoperative detection of biologic variables of gastric cancer and malignant condition of gastric remnant cells obtained by endoscopic biopsy. Oncology 1994; 51:479-484.
18. 18 Ohno S, Mori M, Tsutsui S, et al: Growth patterns and prognosis of submucosal carcinoma of the esophagus. Cancer 1991; 68:335-340.
19. 19 Matsuura H, Sugimachi K, Ueo H: Malignant potentiality of squamous cell carcinoma of the esophagus predictable by DNA analysis. Cancer 1986; 57:1810-1814.
20. 20 Banks L, Matlashewski G, Crawford L: Isolation of human p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 1986; 159:529-534.
21. 21 Shimaya K, Shiozaki H, Inoue M, et al: Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma. Virchows Arch A Pathol Anat Histopathol 1993; 422:271-276.
22. 22 Wang DY, Xiang YY, Tanaka M, et al: High prevalence of p53 protein overexpression in patients with esophageal cancer and its relationship to progression and prognosis in Linxian, China. Cancer 1994; 74:3089-3096.
23. 23 Sarbia M, Porschen R, Borchard F, et al: p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 1994; 74:2218-2223.
24. 24 Kawamura T, Goseki N, Koike M, et al: Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa. Cancer 1996; 77:843-849.
25. 25 Yonemura Y, Kimura H, Fushida S, et al: Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy. Cancer 1993; 71:2448-2453.
26. 26 Bauer KD, Merker DE, Winter JN, et al: Prognostic implication of ploidy and proliferative activity in diffuse large cell lympbomas. Cancer Res 1986; 46:3137-3178.
27. 27 Schutte B, Reynders MM, Wigger T, et al: Retrospective analysis of the prognostic significance of DNA content and proliftirative activity in large bowel carcinoma. Cancer Res 1987; 47:5494-5496.